IBM Stock Surges After Analyst "Overweight" Rating
IBM stock jumped 10.3% to $328.47 after Barclays upgraded it to 'overweight' with a $350 price target, citing strong software revenue and quantum computing momentum. Analysts are overwhelmingly bullish, with 12 of 21 ratings as 'strong buy' or 'buy', while options traders show extreme call buying, signaling high expectations for further gains.
IBM shares rose 10.3% in premarket trading to $328.47 following Barclays' initiation of coverage with an 'overweight' rating and a $350 price target. The firm highlighted IBM’s software segment, which accounts for nearly half of its revenue, and its dominance among large, regulated enterprises. The upgrade comes as IBM’s stock has already surged 17.3% in the past week, marking its largest weekly gain since April 2001, and is up 15.1% year-over-year. Traders are showing strong optimism, with IBM’s 10-day call/put volume ratio at 5.48—ranking in the top 2% of readings over the past year—and its 50-day ratio at 3.60, the highest in a decade. Analyst sentiment backs this bullishness, as 10 of 21 covering analysts rate IBM as a 'strong buy' and two as 'buy,' compared to eight 'holds' and one 'strong sell.' The stock’s recent rally has pushed its 14-day relative strength index (RSI) to 86.8, indicating overbought conditions after a rebound from May lows near $212. IBM’s Schaeffer’s Volatility Scorecard (SVS) stands at 88 out of 100, suggesting the stock has historically outperformed volatility expectations. Barclays’ upgrade follows a string of quantum computing announcements that have already boosted investor confidence. The company’s ability to maintain momentum in high-growth areas like software and quantum technology remains a key driver for its stock performance.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.